You are in: eMedicine Specialties > Dermatology > REACTIVE AND INFLAMMATORY DERMATOSES Asteatotic EczemaArticle Last Updated: Oct 5, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Centracare Clinic Christina K Anderson is a member of the following medical societies: American Academy of Dermatology Coauthor(s): O Fred Miller III, MD, Director, Department of Dermatology, Pennsylvania State Geisinger Medical Center; Susan Cooper, MRCGP, MRCP, MD, Consultant Dermatologist, Department of Dermatology, Churchill Hospital, Oxford, United Kingdom Editors: Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center; Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System Author and Editor Disclosure Synonyms and related keywords: asteatotic dermatitis, eczema craquelé, eczema craquelatum, xerotic eczema, winter itch, eczema hiemalis, eczema fendille, etat craquelé INTRODUCTIONBackgroundFirst described by Brocq in 1907, using the term eczema craquelé, asteatotic dermatitis is characterized by pruritic, dry, cracked, and polygonally fissured skin with irregular scaling. It most commonly occurs on the shins of elderly patients, but it may occur on the hands and the trunk. In 1971, Domonkos described the appearance of this dermatitis as cracked porcelain. The pattern of cracking has been likened to a crazy pavement pattern. In 1999, Fitzpatrick likened asteatotic eczema to a dried-up riverbed. According to Caplan, superficial bleeding and fissures can occur as the epidermis loses water, as it splits, and as it cracks deeply enough to disrupt papillary dermal capillaries. The inflammation can be associated with asymmetric leg edema. Eczema with increased lichenification occasionally supervenes as patients rub and scratch the pruritic areas. The eruption can be generalized or localized. Generalized asteatosis is a distinct entity and should provoke a search for possible associated diseases. Guillet divides the localized forms into 4 types:
PathophysiologyInitially, excess water loss from the epidermis results in dehydration of the stratum corneum with upward curling of corneocytes. The outer keratin layers require 10-20% water concentration to maintain their integrity. A significant decrease in free fatty acids in the stratum corneum is present in people with asteatotic dermatitis. Stratum corneum lipids act as water modulators, and cutaneous loss of these lipids can increase transepidermal water loss to 75 times that of healthy skin. Elderly persons with decreased sebaceous and sweat gland activity, patients on antiandrogen therapy, people using degreasing agents, and people bathing without replacing natural skin emollients lost to bath water are at risk for asteatotic eczema. When the stratum corneum loses water, the cells shrink. A significantly decreased cellular volume can stress the skin's elasticity, creating fissures. Edema in the dermis leads to additional stretch on the overlying epidermis. Fissures rupture dermal capillaries, causing clinical bleeding. The disruption of cutaneous integrity can result in inflammation with risk of infection. Transepidermal absorption of allergens and irritants is increased as the epidermis is damaged, increasing susceptibility to allergic contact dermatitis and irritant contact dermatitis. Allergic contact dermatitis and irritant contact dermatitis may cause a persistent and possibly more extensive dermatitis despite therapy. Furthermore, low environmental humidity contributes to xerosis, creating a clinical picture of asteatotic dermatitis in some dermatologic conditions, such as atopic dermatitis. FrequencyUnited StatesSeasonality is prominent, and most patients present in the winter months, especially in areas where indoor humidity is decreased by heating. The frequency of asteatotic dermatitis is increased in the northern United States, particularly during the winter season. Mortality/MorbidityAlthough most cases resolve without ill effects, asteatotic dermatitis can be chronic with relapses frequent during the winter months and during times of low humidity. SexMen older than 60 years develop asteatotic dermatitis more commonly than women. AgeThe median patient age at presentation is 69 years. Asteatosis can also occur in young people. CLINICALHistoryDuring the winter months, an elderly person classically presents with pruritic and dry skin with dermatitis on the pretibial areas. Sometimes, the dysesthesia may be described as a pinprick or biting sensation.
Physical
CausesMultiple etiologic factors may coexist to cause asteatotic dermatitis, including the following:
DIFFERENTIALSCellulitis Contact Dermatitis, Allergic Contact Dermatitis, Irritant Stasis Dermatitis Thrombophlebitis
| |||||||||||||||||||||||||||||||||||||
| Drug Name | Triamcinolone acetonide (Aristocort) |
|---|---|
| Description | For inflammatory dermatosis responsive to steroids; decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. Available in ointment (0.1%) and cream (0.025%, 0.1%, 0.5%). |
| Adult Dose | Apply thin film bid/tid to response |
| Pediatric Dose | Apply as in adults |
| Contraindications | Documented hypersensitivity; fungal, viral, and bacterial skin infections |
| Interactions | None reported |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Prolonged use causes striae and atrophy; do not use in decreased skin circulation; prolonged use, applications over large areas, and use of potent steroids and occlusive dressings may result in systemic absorption; systemic absorption may cause Cushing syndrome, reversible HPA-axis suppression, hyperglycemia, and glycosuria |
| Media file 1: Asteatotic dermatitis on the lower extremity. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 2: Asteatotic dermatitis on the lower extremity. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 3: Asteatotic dermatitis on the lower extremity. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Oct 5, 2006